• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

工程化哺乳动物RNA干扰可引发抗病毒保护,从而无需干扰素反应。

Engineered Mammalian RNAi Can Elicit Antiviral Protection that Negates the Requirement for the Interferon Response.

作者信息

Benitez Asiel Arturo, Spanko Laura Adrienne, Bouhaddou Mehdi, Sachs David, tenOever Benjamin Robert

机构信息

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Department of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

出版信息

Cell Rep. 2015 Nov 17;13(7):1456-1466. doi: 10.1016/j.celrep.2015.10.020. Epub 2015 Nov 5.

DOI:10.1016/j.celrep.2015.10.020
PMID:26549455
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4654977/
Abstract

Although the intrinsic antiviral cell defenses of many kingdoms utilize pathogen-specific small RNAs, the antiviral response of chordates is primarily protein based and not uniquely tailored to the incoming microbe. In an effort to explain this evolutionary bifurcation, we determined whether antiviral RNAi was sufficient to replace the protein-based type I interferon (IFN-I) system of mammals. To this end, we recreated an RNAi-like response in mammals and determined its effectiveness to combat influenza A virus in vivo in the presence and absence of the canonical IFN-I system. Mammalian antiviral RNAi, elicited by either host- or virus-derived small RNAs, effectively attenuated virus and prevented disease independently of the innate immune response. These data find that chordates could have utilized RNAi as their primary antiviral cell defense and suggest that the IFN-I system emerged as a result of natural selection imposed by ancient pathogens.

摘要

尽管许多生物界的内在抗病毒细胞防御利用病原体特异性小RNA,但脊索动物的抗病毒反应主要基于蛋白质,并非专门针对入侵微生物定制。为了解释这种进化分歧,我们确定抗病毒RNA干扰是否足以取代哺乳动物基于蛋白质的I型干扰素(IFN-I)系统。为此,我们在哺乳动物中重建了类似RNA干扰的反应,并确定其在存在和不存在经典IFN-I系统的情况下在体内对抗甲型流感病毒的有效性。由宿主或病毒衍生的小RNA引发的哺乳动物抗病毒RNA干扰有效地减轻了病毒感染并独立于先天免疫反应预防了疾病。这些数据表明,脊索动物本可以利用RNA干扰作为其主要的抗病毒细胞防御,并表明IFN-I系统是古代病原体施加的自然选择的结果。

相似文献

1
Engineered Mammalian RNAi Can Elicit Antiviral Protection that Negates the Requirement for the Interferon Response.工程化哺乳动物RNA干扰可引发抗病毒保护,从而无需干扰素反应。
Cell Rep. 2015 Nov 17;13(7):1456-1466. doi: 10.1016/j.celrep.2015.10.020. Epub 2015 Nov 5.
2
Engineered virus-encoded pre-microRNA (pre-miRNA) induces sequence-specific antiviral response in addition to nonspecific immunity in a fish cell line: convergence of RNAi-related pathways and IFN-related pathways in antiviral response.工程化病毒编码的前体微小RNA(pre-miRNA)在鱼类细胞系中除了诱导非特异性免疫外,还能引发序列特异性抗病毒反应:抗病毒反应中RNA干扰相关途径和干扰素相关途径的汇聚
Antiviral Res. 2008 Dec;80(3):316-23. doi: 10.1016/j.antiviral.2008.07.005. Epub 2008 Aug 5.
3
Antiviral innate immune response of RNA interference.RNA干扰的抗病毒天然免疫反应
J Infect Dev Ctries. 2014 Jul 14;8(7):804-10. doi: 10.3855/jidc.4187.
4
ADAR1 Biology Can Hinder Effective Antiviral RNA Interference.ADAR1 生物学可以阻碍有效的抗病毒 RNA 干扰。
J Virol. 2023 Apr 27;97(4):e0024523. doi: 10.1128/jvi.00245-23. Epub 2023 Apr 5.
5
Interferons and microRNAs.干扰素和 microRNAs。
J Interferon Cytokine Res. 2010 Nov;30(11):825-8. doi: 10.1089/jir.2010.0080. Epub 2010 Oct 12.
6
The Nucleocapsid Protein of Coronaviruses Acts as a Viral Suppressor of RNA Silencing in Mammalian Cells.冠状病毒的核衣壳蛋白在哺乳动物细胞中作为RNA沉默的病毒抑制因子发挥作用。
J Virol. 2015 Sep;89(17):9029-43. doi: 10.1128/JVI.01331-15. Epub 2015 Jun 17.
7
Antiviral RNAi in Insects and Mammals: Parallels and Differences.昆虫和哺乳动物中的抗病毒 RNAi:相似与差异。
Viruses. 2019 May 16;11(5):448. doi: 10.3390/v11050448.
8
RNAi-mediated antiviral immunity in mammals.哺乳动物中的 RNAi 介导的抗病毒免疫。
Curr Opin Virol. 2018 Oct;32:9-14. doi: 10.1016/j.coviro.2018.07.008. Epub 2018 Jul 14.
9
Human Virus-Derived Small RNAs Can Confer Antiviral Immunity in Mammals.人类病毒来源的小 RNA 可在哺乳动物中赋予抗病毒免疫。
Immunity. 2017 Jun 20;46(6):992-1004.e5. doi: 10.1016/j.immuni.2017.05.006.
10
Homologous recombination is an intrinsic defense against antiviral RNA interference.同源重组是抗病毒 RNA 干扰的固有防御机制。
Proc Natl Acad Sci U S A. 2018 Sep 25;115(39):E9211-E9219. doi: 10.1073/pnas.1810229115. Epub 2018 Sep 12.

引用本文的文献

1
Invasion by exogenous RNA: cellular defense strategies and implications for RNA inference.外源RNA的入侵:细胞防御策略及其对RNA干扰的影响
Mar Life Sci Technol. 2023 Nov 24;5(4):573-584. doi: 10.1007/s42995-023-00209-7. eCollection 2023 Nov.
2
Small Interfering RNA for Gliomas Treatment: Overcoming Hurdles in Delivery.用于胶质瘤治疗的小干扰RNA:克服递送障碍
Front Cell Dev Biol. 2022 Jul 8;10:824299. doi: 10.3389/fcell.2022.824299. eCollection 2022.
3
Ancient viral integrations in marsupials: a potential antiviral defence.有袋类动物中的古代病毒整合:一种潜在的抗病毒防御机制。
Virus Evol. 2021 Sep 2;7(2):veab076. doi: 10.1093/ve/veab076. eCollection 2021.
4
A Requirement for Argonaute 4 in Mammalian Antiviral Defense.Argonaute 4 在哺乳动物抗病毒防御中的需求。
Cell Rep. 2020 Feb 11;30(6):1690-1701.e4. doi: 10.1016/j.celrep.2020.01.021.
5
Synthetic Virology: Building Viruses to Better Understand Them.合成病毒学:构建病毒以更好地理解它们。
Cold Spring Harb Perspect Med. 2020 Nov 2;10(11):a038703. doi: 10.1101/cshperspect.a038703.
6
Harnessing host-virus evolution in antiviral therapy and immunotherapy.在抗病毒治疗和免疫治疗中利用宿主-病毒的进化。
Clin Transl Immunology. 2019 Jul 8;8(7):e1067. doi: 10.1002/cti2.1067. eCollection 2019.
7
Antiviral RNAi in Insects and Mammals: Parallels and Differences.昆虫和哺乳动物中的抗病毒 RNAi:相似与差异。
Viruses. 2019 May 16;11(5):448. doi: 10.3390/v11050448.
8
Slicing and dicing viruses: antiviral RNA interference in mammals.切割病毒:哺乳动物中的抗病毒 RNA 干扰。
EMBO J. 2019 Apr 15;38(8). doi: 10.15252/embj.2018100941. Epub 2019 Mar 14.
9
MicroRNA-Attenuated Virus Vaccines.微小RNA减毒病毒疫苗
Noncoding RNA. 2018 Oct 2;4(4):25. doi: 10.3390/ncrna4040025.
10
Homologous recombination is an intrinsic defense against antiviral RNA interference.同源重组是抗病毒 RNA 干扰的固有防御机制。
Proc Natl Acad Sci U S A. 2018 Sep 25;115(39):E9211-E9219. doi: 10.1073/pnas.1810229115. Epub 2018 Sep 12.

本文引用的文献

1
In Vivo RNAi Screening Identifies MDA5 as a Significant Contributor to the Cellular Defense against Influenza A Virus.体内RNA干扰筛选确定MDA5是细胞抗甲型流感病毒防御的重要贡献者。
Cell Rep. 2015 Jun 23;11(11):1714-26. doi: 10.1016/j.celrep.2015.05.032. Epub 2015 Jun 11.
2
Cross-species comparative analysis of Dicer proteins during Sindbis virus infection.辛德毕斯病毒感染期间Dicer蛋白的跨物种比较分析
Sci Rep. 2015 May 29;5:10693. doi: 10.1038/srep10693.
3
Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates.脂质纳米颗粒siRNA治疗埃博拉病毒-马科纳感染的非人灵长类动物。
Nature. 2015 May 21;521(7552):362-5. doi: 10.1038/nature14442. Epub 2015 Apr 22.
4
The Red Queen's long race: human adaptation to pathogen pressure.红皇后的漫长竞赛:人类对病原体压力的适应
Curr Opin Genet Dev. 2014 Dec;29:31-8. doi: 10.1016/j.gde.2014.07.004. Epub 2014 Aug 24.
5
Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA.非人灵长类动物中的马尔堡病毒感染:脂质包裹的小干扰RNA的治疗性处理
Sci Transl Med. 2014 Aug 20;6(250):250ra116. doi: 10.1126/scitranslmed.3009706.
6
Virus meets host microRNA: the destroyer, the booster, the hijacker.病毒与宿主微小RNA:毁灭者、助推者、劫持者。
Mol Cell Biol. 2014 Oct;34(20):3780-7. doi: 10.1128/MCB.00871-14. Epub 2014 Jul 21.
7
Antiviral responses in mouse embryonic stem cells: differential development of cellular mechanisms in type I interferon production and response.鼠胚胎干细胞中的抗病毒反应:I 型干扰素产生和反应中细胞机制的差异发育。
J Biol Chem. 2014 Sep 5;289(36):25186-98. doi: 10.1074/jbc.M113.537746. Epub 2014 Jun 25.
8
The Mammalian response to virus infection is independent of small RNA silencing.哺乳动物对病毒感染的反应不依赖于小RNA沉默。
Cell Rep. 2014 Jul 10;8(1):114-25. doi: 10.1016/j.celrep.2014.05.038. Epub 2014 Jun 19.
9
Silencing of neurotropic flavivirus replication in the central nervous system by combining multiple microRNA target insertions in two distinct viral genome regions.通过在两个不同的病毒基因组区域中组合多个 microRNA 靶插入来沉默中枢神经系统中的亲神经性黄病毒复制。
Virology. 2014 May;456-457:247-58. doi: 10.1016/j.virol.2014.04.001. Epub 2014 Apr 19.
10
Replication of many human viruses is refractory to inhibition by endogenous cellular microRNAs.许多人类病毒的复制对内源性细胞 microRNAs 的抑制作用具有抗性。
J Virol. 2014 Jul;88(14):8065-76. doi: 10.1128/JVI.00985-14. Epub 2014 May 7.